N-Acetyl GD3

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

32 reference for EP0062

sort by year Reference detail
1 Kotani M, Terashima T, Tai T.
Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex.
Brain Res. 1995 Nov 27;700(1-2):40-58
PMID: 8624728
2 Kawashima I, Nagata I, Tai T.
Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies.
Brain Res. 1996 Sep 2;732(1-2):75-86
PMID: 8891271
3 Kotani M, Kawashima I, Ozawa H, Ogura K, Ishizuka I, Terashima T, Tai T.
Immunohistochemical localization of minor gangliosides in the rat central nervous system.
Glycobiology. 1994 Dec ;4(6):855-65
PMID: 7734848
4 Kawashima I, Ozawa H, Kotani M, Suzuki M, Kawano T, Gomibuchi M, Tai T.
Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis.
J Biochem (Tokyo). 1993 Aug ;114(2):186-93
PMID: 8262898
5 Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL.
Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65
PMID: 15464996
6 Ozawa H, Kotani M, Kawashima I, Tai T.
Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides.
Biochim Biophys Acta. 1992 Jan 24;1123(2):184-90
PMID: 1371229
7 Zenita K, Hirashima K, Shigeta K, Hiraiwa N, Takada A, Hashimoto K, Fujimoto E, Yago K, Kannagi R.
Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages.
J Immunol. 1990 Jun 1;144(11):4442-51
PMID: 2111348
8 Cheresh DA, Harper JR, Schulz G, Reisfeld RA.
Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells.
Proc Natl Acad Sci U S A. 1984 Sep ;81(18):5767-71
PMID: 6385004
9 Welte B, Handgretinger R, Rassner G, Fierlbeck G.
Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma.
Exp Dermatol. 1997 Apr ;6(2):64-9
PMID: 9209886
10 Tai T, Kawashima I, Tada N, Dairiki K.
Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
J Biochem (Tokyo). 1988 Apr ;103(4):682-7
PMID: 3170507
11 Fukuta S, Werkmeister JA, Burns GF, Ginsburg V, Magnani JL.
Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
J Biol Chem. 1987 Apr 5;262(10):4800-3
PMID: 2435716
12 Werkmeister JA, Triglia T, Mackay IR, Dowling JP, Varigos GA, Morstyn G, Burns GF.
Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Cancer Res. 1987 Jan 1;47(1):225-30
PMID: 3791209
13 Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ.
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
J Exp Med. 1982 Apr 1;155(4):1133-47
PMID: 7061953
14 Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Cancer Res. 1989 Jan 1;49(1):191-6
PMID: 2908845
15 Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ.
Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
Proc Natl Acad Sci U S A. 1987 Apr ;84(8):2416-20
PMID: 3031684
16 Tai T, Kawashima I, Furukawa K, Lloyd KO.
Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.
Arch Biochem Biophys. 1988 Jan ;260(1):51-5
PMID: 2449128
17 Brodin T, Hellstrom I, Hellstrom KE, Karlsson KA, Sjogren HO, Stromberg N, Thurin J.
Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
Biochim Biophys Acta. 1985 Dec 4;837(3):349-53
PMID: 3840699
18 Watarai S, Onuma M, Yasuda T.
Production of monoclonal antibodies specific for ganglioside GD3.
J Biochem (Tokyo). 1991 Dec ;110(6):889-95
PMID: 1724444
19 He X, Wikstrand CJ, Fredman P, Mansson JE, Svennerholm L, Bigner DD.
GD3 expression by cultured human tumor cells of neuroectodermal origin.
Acta Neuropathol (Berl). 1989 ;79(3):317-25
PMID: 2609939
20 Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA.
Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
Cancer Res. 1986 Oct ;46(10):5112-8
PMID: 3019521
21 Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K.
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
J Cell Biol. 1986 Mar ;102(3):688-96
PMID: 3005335
22 Hedberg KM, Mahesparan R, Read TA, Tysnes BB, Thorsen F, Visted T, Bjerkvig R, Fredman P.
The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
Neuropathol Appl Neurobiol. 2001 Dec ;27(6):451-64
PMID: 11903928
23 Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE, Smereczynska M, Karlsson KA, Clark WM Jr, Steplewski Z, et al.
Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Cancer Res. 1987 Mar 1;47(5):1229-33
PMID: 3815333
24 Hildebrandt H.
Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample.
FEBS Lett. 1996 Jun 10;388(1):29-33
PMID: 8654583
25 Townson K, Greenshields KN, Veitch J, Nicholl D, Eckhardt M, Galanina O, Bovin N, Samain E, Antoine T, Bundle D, Zhang P, Ling CC, Willison HJ.
Sulfatide binding properties of murine and human antiganglioside antibodies.
Glycobiology. 2007 Nov ;17(11):1156-66
PMID: 17855742
26 Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ.
Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
J Clin Invest. 1999 Sep ;104(6):697-708
PMID: 10491405
27 Willison HJ, Townson K, Veitch J, Boffey J, Isaacs N, Andersen SM, Zhang P, Ling CC, Bundle DR.
Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
Brain. 2004 Mar ;127(Pt 3):680-91
PMID: 14960498
28 Boffey J, Nicholl D, Wagner ER, Townson K, Goodyear C, Furukawa K, Furukawa K, Conner J, Willison HJ.
Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes.
J Neuroimmunol. 2004 Jul ;152(1-2):98-111
PMID: 15223242
29 Boffey J, Odaka M, Nicoll D, Wagner ER, Townson K, Bowes T, Conner J, Furukawa K, Willison HJ.
Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire.
J Neuroimmunol. 2005 Aug ;165(1-2):92-103
PMID: 15967512
30 Miyazaki H, Shiku H, Furukawa K.
Differential effects of a murine monoclonal antibody reactive with the disialylgalactosyl residue on the growth of melanoma cells and T cell activation.
Int J Oncol. 1996 Aug ;9(2):241-5
PMID: 21541506
31 Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R, Tai T.
Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
Int J Cancer. 1988 Feb 15;41(2):267-74
PMID: 2448252
32 Dippold WG, Lloyd KO, Li LT, Ikeda H, Oettgen HF, Old LJ.
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Proc Natl Acad Sci U S A. 1980 Oct ;77(10):6114-8
PMID: 6934537